Activation of AMPK induces the recruitment of GLUT4 to the plasma membrane resulting in up-regulated glucose uptake [12,14], and several studies have demonstrated that AMPK and its signaling pathway are potential molecular targets in the development of drugs for the treatment of type 2 diabetes and obesity [36,37]. This evidence concerns the gene SLC2A4 and Obesity.